HomeATXI • OTCMKTS
Avenue Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.91M | -48.62% |
Net income | -1.85M | 57.33% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.50M | 9.64% |
Total assets | 3.59M | 8.58% |
Total liabilities | 1.26M | -10.62% |
Total equity | 2.33M | — |
Shares outstanding | 3.18M | — |
Price to book | 0.23 | — |
Return on assets | -152.01% | — |
Return on capital | -227.44% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.85M | 57.33% |
Cash from operations | -1.19M | 61.99% |
Cash from investing | — | — |
Cash from financing | 2.09M | -53.79% |
Net change in cash | 908.00K | -35.65% |
Free cash flow | -573.63K | 70.73% |
Previous close
$0.25
Day range
$0.20 - $0.26
Year range
$0.17 - $0.38
Market cap
827.74K USD
Avg Volume
4.62K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
2015
Headquarters
Website
Employees
2
